Hospira Celltrion Agreement (NYSE:HSP)
Sandra Kitchen (October 9th, 2009) Writes:
Hospira Inc and Celltrion Healthcare Inc have signed a Business Cooperation Agreement which outlines the business terms of a future distribution agreement in countries like United States of America, Europe, Canada, Australia and New Zealand for eight biogeneric products that are currently under development stages by Celltrion, and five products which are incremental to Hospira’s pipeline. Hospira Inc is a specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness. They are world leader in specialty generic injectable pharmaceuticals and they offer one of the broadest portfolios of generic acute-care and oncology injectables. On the other hand Celltrion Inc is a leading biopharmaceutical company in Korea that specializes in monoclonal antibody capabilities.
Under the distribution agreement between the two biopharmaceutical firms it has been decided that they will collaborate on manufacturing
...Australia, biogeneric products, Biopharmaceutical, biopharmaceutical firms, Canada, Celltrion Healthcare Inc, Celltrion Inc, chairman and CEO, Christopher B. Begley, Europe, FavStocks, generic injectable pharmaceuticals, Hospira Inc., Investing Lessons, Korea, leader, New Zealand, Pharmaceutical, Stocks to Watch, United States of America


![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/gold/t24_au_en_usoz_2.gif)
![[Most Recent Quotes from www.kitco.com]](http://www.kitconet.com/charts/metals/silver/t24_ag_en_usoz_2.gif)








